Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Spotlight Correspondence
  • Published:

Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Saglio G, Guerrasio A, Rosso C, Zaccaria A, Tassinari A, Serra A et al. New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1990; 76: 1819–1824.

    CAS  PubMed  Google Scholar 

  2. Pane F, Frigeri F, Sindona M, Luciano L, Ferrara F, Cimino R et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 1996; 88: 2410–2414.

    CAS  PubMed  Google Scholar 

  3. Briz M, Vilches C, Cabrera R, Fores R, Fernandez MN . Typical chronic myelogenous leukemia with e19a2 junction BCR/ABL transcript. Blood 1997; 90: 5024–5025.

    CAS  PubMed  Google Scholar 

  4. How GF, Tan LT, Lim LC . Chronic myeloid leukemia with e19a2 (c3a2) BCR/ABL fusion junction – is it truly a benign disease? Leukemia 1998; 12: 1166–1167.

    Article  CAS  PubMed  Google Scholar 

  5. Polak J, Koza V, Cetkovsky P, Haskovec C . An accelerated-phase CML patient with e19a2 junction of BCR/ABL gene – the first case of transplanted CML with micro bcr. Bone Marrow Transplant 2000; 25: 1109–1110.

    Article  CAS  PubMed  Google Scholar 

  6. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031–1037.

    Article  CAS  PubMed  Google Scholar 

  7. Kim YJ, Kim DW, Lee S, Kim HJ, Kim YL, Hwang JY et al. Comprehensive comparison of FISH, RT-PCR, and RQ-PCR for monitoring the bcr-abl gene after hematopoietic stem cell transplantation in CML. Eur J Haematol 2002; 68: 272–280.

    Article  CAS  PubMed  Google Scholar 

  8. Cross NC, Melo JV, Feng L, Goldman JM . An optimized multiplex polymerase chain reaction for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia 1994; 8: 186–189.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (01-PJ10-PG6-01GN16-0005).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D-W Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, JJ., Kim, HJ., Kim, YJ. et al. Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts. Leukemia 18, 1539–1540 (2004). https://doi.org/10.1038/sj.leu.2403454

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403454

This article is cited by

Search

Quick links